This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Sakert, T. Articles by Christlieb, I. Search for Related Content PubMed PubMed Citation Articles by Sakert, T. Articles by Christlieb, I. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Coronary Artery Bypass Surgery Social Bookmarking                         What's this?

Cell saver efficacy for routine coronary artery bypass surgery

Allegheny General Hospital, Pittsburgh, Pennsylvania

William Gil

Allegheny General Hospital, Pittsburgh, Pennsylvania

Ian Rosenberg

Allegheny General Hospital, Pittsburgh, Pennsylvania

Deborah Carpellotti

Allegheny General Hospital, Pittsburgh, Pennsylvania

Kathy Boss

Allegheny General Hospital, Pittsburgh, Pennsylvania

Tim Williams

Allegheny General Hospital, Pittsburgh, Pennsylvania

Joseph Ferneding

Allegheny General Hospital, Pittsburgh, Pennsylvania

Ignacio Christlieb

Allegheny General Hospital, Pittsburgh, Pennsylvania

A retrospective study was conducted to determine the effect of intraoperative Haemonetics Cell Saver® (HCS) usage on postoperative homologous blood product requirements in CABG patients. From 1 January to 31 December 1993, 516 patients without renal disease or postoperative surgical or gastrointestinal haemorrhage had elective, first-time CABG surgery. The HCS was utilized in 435 of these patients (Group CS) and in 81 patients the HCS was excluded (Group NCS). Preoperative patient variables were similar in the group. We evaluated the HCS effect on blood product transfusion by comparing x units of red blood cells (RBC), fresh frozen plasma (FFP) and platelets (PLTS) transfused per patient between groups CS and NCS. There were no differences in the x units of RBC (1.9 ± 2.7 CS vs 1.8 ± 1.5 NCS) or in the RBC transfusion rate (48% CS vs 50% NCS). There were also no significant differences between the groups in x units of FFP (0.9 ± 0.8 CS vs 0.4 ± 0.9 NCS) or PLTS (0.7 ± 3.1 CS vs 0.4 ± 2.5 NCS), or in the percentage of patients receiving these products (12% CS vs 8% NCS). These data provide no evidence that the use of the HCS decreases the amount of homologous blood bank products required postoperatively in patients having routine first-time CABG surgery. The current era of aggressive blood conservation may have limited the role of the HCS in routine CABG surgery.

Perfusion, Vol. 11, No. 1, 71-77 (1996)
DOI: 10.1177/026765919601100110


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				The Society of Thoracic Surgeons Blood Conservatio, V. A. Ferraris, S. P. Ferraris, S. P. Saha, E. A. Hessel II, C. K. Haan, B. D. Royston, C. R. Bridges, R. S.D. Higgins, G. Despotis, et al. Perioperative Blood Transfusion and Blood Conservation in Cardiac Surgery: The Society of Thoracic Surgeons and The Society of Cardiovascular Anesthesiologists Clinical Practice Guideline Ann. Thorac. Surg., May 1, 2007; 83(5_Supplement): S27 - S86. [Abstract] [Full Text] [PDF]

				M. J Cromer and D. R Wolk A minimal priming technique that allows for a higher circulating hemoglobin on cardiopulmonary bypass Perfusion, September 1, 1998; 13(5): 311 - 313. [Abstract] [PDF]